|
|
|
| |
 |
|
|
|
推薦指數：
|
|
- 內容介紹
|
The Sanford Guide to Antimicrobial Therapy 2026 (Pocket Edition)
by MD David N. Gilbert (Author), MD Henry F. Chambers (Author), MD Michael S. Saag (Author)
Publisher : Antimicrobial Therapy, Inc.
Edition : Pocket Edition
Language : English
Print length : 361 pages
ISBN-10 : 194427233X
ISBN-13 : 978-1944272333
Item Weight : 13 ounces
2026
Sanford Guide helps you make the best infectious diseases treatment decisions, fast. This Pocket Edition has an approximate font size of 3 points. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians, The Sanford Guide to Antimicrobial Therapy provides convenient, concise, and reliable information. The book includes a FREE 1-month trial of Sanford Guide Antimicrobial All Access, which provides expanded content, interactive tables and tools, and constant updates. Coverage Clinical syndromes, Pathogens (Bacterial, Fungal, Mycobacterial, Parasitic, Viral), Anti-infective agents (Dosing, Pediatric adjustments, Renal adjustments, Adverse effects, Activity, Pharmacology, Interactions), and Preventative therapy. The 2025-2026 respiratory virus season remains dominated by the triple threat posed by COVID-19, RSV and influenza. Measles outbreaks are a continuing concern. Vaccination remains the cornerstone of prevention. For comprehensive coverage, we direct you to Sanford Guide digital content (sold separately - please inquire), which is constantly updated. Throughout this edition we have updated treatment recommendations based on recent references and guidelines. Also, we have removed many older references that have been superseded or are simply no longer necessary. Major updates include: Table 1—major updates to native valve endocarditis, adult arthritis, complicated urinary tract infections and plague, as well as minor updates to regimens and comments throughout. Table 3—duration of therapy, is substantially revised. Tables 5 and 6—highly resistant bacteria, are substantially revised. Table 7—new desensitization protocols and references added. Table 10A—gets recently approved anti-infectives. Table 12A—pulmonary tuberculosis has a major update. Tables 11, 13 and 14—covering fungal, parasitic and viral infections respectively are updated as needed. Table 15—prophylaxis for dental procedures and candida and cocci prevention are updated for improved clarity. New tables 18A, 18B—cover hepatic impairment dosing and DRESS. Drug information tables covering pediatric dosing, pharmacology, enzyme- and transporter-mediated interactions, renal impairment dosing, obesity dosing are updated throughout.
|
|
|
其他相關書藉
[ 
[